Literature DB >> 28598679

Hypoxia Modulates Epithelial Permeability via Regulation of Vascular Endothelial Growth Factor in Airway Epithelia.

Hyun-Ah Song1, Yoo-Suk Kim2, Hyung-Ju Cho2,3, Soo In Kim1, Min Jung Kang1, Ji Hyun Kim1, Hyun Jin Min2, Ju-Wan Kang2, Joo-Heon Yoon1,2,3,4, Chang-Hoon Kim2,3.   

Abstract

Hypoxia resulting from occlusion of the sinus ostium is known to be one of the major pathogenic mechanisms of sinusitis. Hypoxia-inducible factor (HIF)-1 is a widely known transcription factor that induces the cellular response to hypoxic conditions and activates the transcription of several genes, including vascular endothelial growth factor (VEGF). We hypothesized that induced permeability caused by hypoxia is a major pathophysiologic mechanism of upper airway diseases, such as sinusitis. The aim of this study was to investigate the mechanism of hypoxia-induced hyperpermeability, which mediates increased paracellular permeability and enhanced microbial invasiveness in the airway epithelium. We show that expression of VEGF mRNA and protein and HIF-1α protein increased as a function of time under hypoxia in normal human nasal epithelial cells. Our results also indicate that VEGF expression was induced by transfection with a mammalian expression vector encoding HIF-1 but down-regulated by transfection with small interfering RNA specific for HIF-1α under hypoxic conditions. Results of a transepithelial permeability assay measuring transepithelial electrical resistance indicated that permeability was increased as a function of time under hypoxia and was rescued by anti-VEGF monoclonal antibody (bevacizumab) and small interfering RNA specific for HIF-1α. We detected up-regulated HIF-1α and VEGF expression in mucosal epithelium samples from patients with sinusitis compared with normal mucosal epithelium using Western blotting and immunohistochemical staining. In conclusion, we suggest that the hypoxia-HIF-1α-VEGF axis plays an important role in hyperpermeability of airway epithelial cells, implying a role in the pathophysiology of upper respiratory tract diseases, such as sinusitis.

Entities:  

Keywords:  hypoxia; hypoxia-inducible factor-1; paracellular permeability; sinusitis; vascular endothelial growth factor

Mesh:

Substances:

Year:  2017        PMID: 28598679     DOI: 10.1165/rcmb.2016-0080OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

1.  Neuroprotective effect of heparin Trisulfated disaccharide on ischemic stroke.

Authors:  Gabrielly M D Chiarantin; Lina M Delgado-Garcia; Laura N Zamproni; Marcelo A Lima; Helena B Nader; Ivarne L S Tersariol; Marimélia Porcionatto
Journal:  Glycoconj J       Date:  2021-01-07       Impact factor: 2.916

2.  Oxygen matters: hypoxia as a pathogenic mechanism in rhinosinusitis.

Authors:  Hyung-Ju Cho; Chang-Hoon Kim
Journal:  BMB Rep       Date:  2018-02       Impact factor: 4.778

Review 3.  Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease.

Authors:  Lee K Page; Karl J Staples; C Mirella Spalluto; Alastair Watson; Tom M A Wilkinson
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

4.  Roles Played by the PI3K/Akt/HIF-1α Pathway and IL-17A in the Chinese Subtype of Chronic Sinusitis with Nasal Polyps.

Authors:  Ke-Jia Cheng; Min-Li Zhou; Yong-Cai Liu; Shui-Hong Zhou
Journal:  Mediators Inflamm       Date:  2022-01-15       Impact factor: 4.711

5.  The Effect of TNF and VEGF on the Properties of Ea.hy926 Endothelial Cells in a Model of Multi-Cellular Spheroids.

Authors:  S Sh Gapizov; L E Petrovskaya; L N Shingarova; E V Svirschevskaya; D A Dolgikh; M P Kirpichnikov
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845

6.  Association between Upper-airway Surgery and Ameliorative Risk Markers of Endothelial Function in Obstructive Sleep Apnea.

Authors:  Fan Wang; Yuenan Liu; Huajun Xu; Yingjun Qian; Jianyin Zou; Hongliang Yi; Jian Guan; Shankai Yin
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.